{
    "id": 26642,
    "fullName": "NQO1 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "NQO1 positive indicates the presence of the NQO1 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1728,
        "geneSymbol": "NQO1",
        "terms": [
            "NQO1",
            "DHQU",
            "DIA4",
            "DTD",
            "NMOR1",
            "NMORI",
            "QR1"
        ]
    },
    "variant": "positive",
    "createDate": "06/06/2017",
    "updateDate": "06/06/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11102,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, ARQ761 treatment in 31 patients with an advanced solid tumor resulted in 11 patients overall with stable disease, and a greater disease control rate (65% vs 18%) and 3 month PFS (40% vs 20%) in NQO1 positive patients versus NQO1 negative patients (J Clin Oncol 35, 2017 (suppl; abstr 2517)).",
            "molecularProfile": {
                "id": 27909,
                "profileName": "NQO1 positive"
            },
            "therapy": {
                "id": 3516,
                "therapyName": "ARQ761",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9074,
                    "pubMedId": null,
                    "title": "Phase 1 study of ARQ 761, a ?-lapachone analog that promotes NQO1-mediated programmed cancer cell necrosis",
                    "url": "http://abstracts.asco.org/199/AbstView_199_190411.html"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27909,
            "profileName": "NQO1 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}